期刊文献+

肝移植前后人血清中蛋白质双向电泳图谱比较 被引量:2

Comparision of spectra of human serum protein on two-dimensional gel electrophoresis before and after liver transplantation
下载PDF
导出
摘要 目的研究比较肝移植前后人血清蛋白质双向电泳图谱,探索人肝脏移植后免疫排斥和耐受反应的机制。方法用Aurum Serum Protein Mini Kit对血清预处理,进行双向凝胶电泳(2-DE)分离。Image Master 2D Platinum分析凝胶图谱。结果建立了移植前和移植后24 h、10 d、30 d的人血清双向电泳图谱。与移植前相比,共筛选出明显表达差异的蛋白质斑点15个,其中在移植后蛋白斑点表达上调的14个,表达下调的1个。结论初步建立了肝移植后的人血清蛋白质组学分析方法,差异表达蛋白质点的发现为深入研究肝移植术后免疫耐受和免疫排斥的机制提供了线索。 Objective To compare of the spectra of human serum proteins on two - dimensional gel electrophoresis before and after liver transplantation for studying the mechanism of the immune rejection and immune tolerance after human liver transplantation. Methods Highly abundant proteins in serum were preprocessed using aurum serum protein mini kit and were separated by 2 - DE. The spectra were analyzed by using Image Master 2D Platinum soliware. Results The 2 - D spectra of human serum proteins before and 'after liver transplantation 24h,10d and 30d were established. Among them 15 protein spots had significant change, 14 protein were up -regulated and one protein was down -regulated. Conclusions Proteomics of human serum after liver transplantation is initially established. The dis- covery of differentially expressed proteins may provide further insight into molecular mechanisms of immune rejection and immune tolerance.
出处 《武警医学》 CAS 2013年第12期1066-1068,1072,共4页 Medical Journal of the Chinese People's Armed Police Force
基金 武警总医院二类课题(WZ2011019)
关键词 肝移植 免疫排斥 免疫耐受 血清 双向电泳 liver transplantation immune rejection immune tolerance serum 2 - DE
  • 相关文献

参考文献13

  • 1Testino G,Patussi V,Scafato E.Alcoholic liver disease and liver transplantation[J] .Recenti Prog Med,2013,104(1):17-22.
  • 2岳扬,安丽娜,臧运金,吴凤东,张庆,朱晓丹,邹卫龙,陈新国.心脏死亡后器官捐献供肝肝移植7例[J].武警医学,2012,23(8):712-713. 被引量:9
  • 3Gordon E J,Daud A,Caicedo J C,et al.Informed consent and decision-making about adult-to-adult living donor liver transplantation:a systematic review of empirical research[J] .Transplantation,2011,92(12):1285-1296.
  • 4关兆杰,杨洋,邹卫龙,陈新国,李威,刘煜,朱晓丹,臧运金,沈中阳.肝移植治疗原发性胆汁性肝硬化[J].武警医学,2010,21(12):1053-1055. 被引量:2
  • 5Kamada N,Davies H S,Roser B.Reversal of transplantation immunity by liver grafting[J] .Nature,1981,292(5826):840-842.
  • 6汪楠,袁苏徐,胡文杰.肝癌肝移植术后停用免疫抑制剂1例报告[J].实用癌症杂志,2012,27(2):211-211. 被引量:2
  • 7Doehner W.Diagnostic biomarkers in cardiovascular disease:the proteomics approach[J] .Eur Heart J,2012,33(18):2249-2251.
  • 8Bharti A,Ma P C,Salgia R.Biomarker discovery in lung cancer--promises and challenges of clinical proteomics[J] .Mass Spectrom Rev,2007,26(3):451-466.
  • 9Sigdel T K,Gao X,Sarwal M M.Protein and peptide biomarkers in organ transplantation[J] .Biomark Med,2012,6(3):259-271.
  • 10Mortz E,Krogh T N,Vorum H,et al.Improved silver staining protocols for high sensitivity protein identification using matris assisted laser desorption/ionization time of flight analysis[J] .Proteomics,2001,11:359-363.

二级参考文献18

  • 1陈忠华.同种肝脏移植免疫特惠器官现象及其临床意义[J].中华肝脏病杂志,2005,13(3):221-221. 被引量:5
  • 2Eric M G,Carlo S,Howard J W,et al.Risk factors and comorbidities in primary biliary cirrhosis:a controlled interview-based study of 1032 patients[J].Hepatology 2005,42(5):1194 -1202.
  • 3Grambsch P M,Dickson E R,Wiesner R H,et al.Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients[J].Mayo Clin Proc,1989,64(1):699-704.
  • 4Kim W R,Wiesner R H,Therneau T M,et al.Optimal timing of liver transplantation for primary biliary cirrhosis[J].Hepatology,1998,28(6):33-38.
  • 5Hayashi M,Keeffe E B,Krams S M,et al.Allograft rejection after liver transplantation for autoimmune liver diseases[J].Liver Transpl Surg,1998,4(7):208-214.
  • 6Seiler C A,Dufour J F,Renner E L,et al.Primary liver disease as a determinant for acute rejection after liver transplantation[J].Langenbecks Arch Surg,1999,384(1):259-263.
  • 7Edmund Q S,Marlon F L,Robert M G,et al.The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation[J].Transplantation,2003,76(11);1583-1588.
  • 8Sylvestre P B,Batts K P,Burgart L J,et al.Recurrence of primary biliary cirrhosis after liver transplantation:Histologic estimate of incidence and natural history[J].Liver Transpl,2003,9(10):1086-1093.
  • 9Silveira M G,Talwalkar J A,Lindlor K D,et al.Recurrent primary biliary cirrhosis after liver transplantation[J].Am J Transpl,2010,10(4):720-726.
  • 10Dietmar A J,Neumann U P,Marcus B,et al.Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients[J].Clini Transpl,2006,20(2):2111-220.

共引文献10

同被引文献46

  • 1叶启发,熊力,明英姿.肝移植的蛋白质组学研究探讨[J].中华普通外科学文献(电子版),2007,1(3):186-188. 被引量:1
  • 2明英姿,熊力,叶启发.进行肝移植蛋白质组学研究可行性探讨[J].中国医学工程,2007,15(2):155-159. 被引量:1
  • 3Okayama A, Miyagi Y, Oshita F, et aI.Proteomic Analysis of Proteins Related to Prognosis of Lung Adenocarcinoma.J Proteome Res. 2014. [Epub ahead of print].
  • 4Martins-de-Souza D.Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder.Dialogues Clin Neurosci. 2014; 16(1 ):63-73.
  • 5Petrotchenko EV, Borchers CH.Modern mass spectrometry-based structural proteomics.Adv Protein Chem Struct Biol. 2014;95:193-213.
  • 6Walsh B J, Molloy MP, Williams KL.The Australian Proteome Analysis Facility (APAF): assembling large scale proteomics through integration and automation.Electrophoresis. 1998; 19(il):1883-1890.
  • 7Ashcroff AE.Protein and peptide identification: the r01e of mass spectrometry in proteomics.Nat Prod Rep. 2003;20(2): 202-215.
  • 8Mo W, Karger BL.Anal~ical aspects of mass spectrometry and proteomics.Curr Opin Chem Biol. 2002;6(5):666-675.
  • 9Lombardi D, Mileo AM.Protein interactions provide new insight into Nm23/nucleoside diphosphate kinase functions.J Bioenerg Biomembr. 2003;35(1):67-71.
  • 10Otero AS.NM23/nucleoside diphosphate kinase and signal transduction.J Bioenerg Biomembr. 2000;32(3):269-275.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部